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O-GlcNAc signaling, and ChREBP expression and activity. —
Bindesbøll, C., Q. Fan, R. C. Nørgaard, L. MacPherson, 
H-B. Ruan, J. Wu, T. Å. Pedersen, K. R. Steffensen, X. Yang, 
J. Matthews, S. Mandrup, H. I. Nebb, and L. M. Grønning-
Wang.  Liver X receptor regulates hepatic nuclear O-GlcNAc 
signaling and carbohydrate responsive element-binding pro-
tein activity.  J. Lipid Res. 2015. 56:  771–785. 
 Supplementary key words lipid metabolism • insulin • glucose • carbo-
hydrate responsive element-binding protein   • carbohydrate responsive 
element-binding protein   • chromatin immunoprecipitation • O-linked 
  - N -acetylglucosamine • O-linked   - N -acetylglucosamine transferase 
 In mammals, excess dietary carbohydrates are converted 
into TGs through de novo lipogenesis (DNL) in liver and 
adipose tissue ( 1 ). Although insulin is a central regulator 
 Abstract  Liver X receptor (LXR)  and LXR  play key 
roles in hepatic de novo lipogenesis through their regula-
tion of lipogenic genes, including sterol regulatory element-
binding protein (SREBP)-1c and carbohydrate responsive 
element-binding protein (ChREBP). LXRs activate lipogenic 
gene transcription in response to feeding, which is believed 
to be mediated by insulin. We have previously shown that 
LXRs are targets for glucose-hexosamine-derived O-linked 
  - N -acetylglucosamine (O-GlcNAc) modifi cation enhancing 
their ability to regulate  SREBP-1c promoter activity in vitro. 
To elucidate insulin-independent effects of feeding on 
LXR-mediated lipogenic gene expression in vivo, we sub-
jected control and streptozotocin-treated LXR  /  +/+ and 
LXR  /    /   mice to a fasting-refeeding regime. We show 
that under hyperglycemic and hypoinsulinemic conditions, 
LXRs maintain their ability to upregulate the expression of 
glycolytic and lipogenic enzymes, including glucokinase (GK), 
SREBP-1c, ChREBP  , and the newly identifi ed shorter iso-
form ChREBP  . Furthermore, glucose-dependent increases 
in LXR/retinoid X receptor-regulated luciferase activity 
driven by the  ChREBP  promoter was mediated, at least in 
part, by O-GlcNAc transferase (OGT) signaling in Huh7 cells. 
Moreover, we show that LXR and OGT interact and colocal-
ize in the nucleus and that loss of LXRs profoundly reduced 
nuclear O-GlcNAc signaling and  ChREBP  promoter binding 
activity in vivo.  In summary, our study provides evidence 
that LXRs act as nutrient and glucose metabolic sensors up-
stream of ChREBP by modulating GK expression, nuclear 
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expression ( 23 ). Mutations of these residues, however, did 
not result in a constitutively active ChREBP ( 24 ), which 
suggests that ChREBP  is regulated by alternative means. 
In this respect, a recent study reported O-GlcNAcylation of 
ChREBP in response to hyperglycemia ( 25 ). Moreover, ad-
enoviral overexpression of OGT in liver increased ChREBP 
O-GlcNAcylation, protein stability, and transactivation of 
liver pyruvate kinase ( L-pk ) and lipogenic genes ( 25 ). The 
lipogenic potential of LXRs was not investigated in that 
study. 
 Several reports show that LXR is essential for SREBP-1c 
activity in response to feeding, as SREBP-1c expression 
and hepatic DNL are drastically reduced in LXR-defi cient 
mice ( 5, 26, 27 ). Although LXR clearly stimulates hepatic 
ChREBP expression after pharmacological activation ( 6 ), 
whether LXR regulates ChREBP under physiological con-
ditions is less clear and may be dependent on insulin, dietary 
carbohydrate, and lipid content ( 26, 27 ). Notably, Herman 
et al. ( 28 ) recently identifi ed a novel variant of ChREBP 
named ChREBP  , which results from an alternative pro-
moter located in exon1b of the  ChREB gene. They further 
showed that glucose metabolism induced transcription of 
ChREBP  , promoting binding of ChREBP  to a carbohy-
drate response element (ChORE) identifi ed in exon1b, 
inducing ChREBP  transcription. Whether LXRs contrib-
ute to isoform-specifi c expression of ChREBP is currently 
not known. 
 To further explore the role of LXR and ChREBP in 
hepatic lipogenesis and to investigate insulin-independent 
effects of feeding on LXR activity, we subjected control and 
streptozotocin (STZ)-treated LXR +/+ and LXR   /   mice to 
a fasting-refeeding regime. Our results demonstrate that 
LXR regulates hepatic  Gk expression and lipogenic genes 
also under hyperglycemic conditions independently of 
insulin. Furthermore, levels of O-GlcNAc-modifi ed LXR 
were increased upon refeeding in both models, support-
ing the notion of LXR as a postprandial glucose-O-GlcNAc 
sensor. In support of our observations in vivo, LXR con-
ferred high glucose responses on the  ChREBP  promoter 
in Huh7 cells, an effect that was signifi cantly inhibited by 
OGT depletion. We further show that nuclear, but not 
cytosolic, protein-O-GlcNAc levels are dramatically lower 
in LXR   /   compared with LXR +/+ mice. Accordingly, O-
GlcNAcylation of ChREBP and the potential of ChREBP  
to induce its target gene  L-pk , was lower in refed LXR   /   
compared with LXR +/+ mice. Combined, our work identi-
fi es LXR as an important integrator of hepatic glucose/
O-GlcNAc metabolism and fatty acid synthesis upstream of 
ChREBP. 
 RESEARCH DESIGN AND METHODS 
 Materials 
 STZ (S0130), GW3965 (G6295), DMSO (D4540), formaldehyde 
(F1635), DMEM (D6046, D6546), fetal bovine serum (F7524), 
 L -glutamine (G7513), 1% penicillin-streptomycin (P4458), and 
D-(+)-glucose solution (G8769) were purchased from Sigma-Aldrich. 
of hepatic DNL, glucose also plays a role in this process 
( 2 ). The liver X receptors (LXRs) [LXR  (NR1H3) and 
LXR  (NR1H2)] are oxysterol-activated nuclear receptors 
with important roles in cholesterol, glucose, and lipid me-
tabolism ( 3, 4 ). LXR  is mainly expressed in liver, adipose, 
intestine, and macrophages, whereas LXR  is ubiquitously 
expressed. Hepatic LXRs regulate the expression of ste-
rol regulatory element-binding protein (SREBP)-1c ( 5 ) 
and carbohydrate responsive element-binding protein 
(ChREBP) ( 6 ), which, together with LXRs, are key regula-
tors of many glycolytic and lipogenic genes, including 
glucokinase (GK) ( 7 ), acetyl-CoA carboxylase (ACC) ( 8 ), 
FAS ( 9 ), and stearoyl CoA desaturase (SCD)1 ( 10 ). 
 In addition to oxysterols and synthetic ligands, our labo-
ratory and others have shown that insulin stimulates the 
lipogenic activity of LXRs in mouse liver ( 11, 12 ). The mech-
anisms involved are poorly understood, but may include 
posttranslational modifi cations [i.e., phosphorylation 
of LXR and/or synthesis of endogenous LXR ligand(s)]. 
Mitro et al. ( 13 ) reported that glucose bound to and acti-
vated LXR; however, these fi ndings are controversial 
because the LXR ligand binding pocket accommodates 
small hydrophobic, rather than hydrophilic, compounds 
( 14 ). We recently reported that LXRs were posttrans-
lationally modified by O-linked   - N -acetylglucosamine 
(O-GlcNAc) in response to glucose, which in turn potenti-
ated their transactivation of  SREBP-1c ( 15 ). O-GlcNAc is a 
dynamically regulated posttranslational modifi cation that 
is catalyzed by O-GlcNAc transferase (OGT). OGT uses 
UDP- N -acetylglucosamine (GlcNAc) as a substrate to add 
GlcNAc in O-glycosidic linkage to serine and threonine 
residues in target proteins, which are removed by O-
GlcNAcase (OGA). The intracellular concentration of 
UDP-GlcNAc is controlled by the nutrient-responsive hex-
osamine biosynthetic pathway (HBP), a branch of glucose 
metabolism ( 16 ). Metabolic fl ux via the HBP is controlled 
by the rate-limiting enzyme glutamine:fructose-6-phosphate 
amidotransferase (GFAT). Concequently, UDP-GlcNAc 
pools are reduced when glucose uptake and glucose-
6-phosphate (G-6-P) synthesis are limited ( 17 ). Because 
OGT activity is highly responsive to UDP-GlcNAc concen-
trations, OGT serves as a unique nutrient sensor ( 16 ). The 
activity of OGT and OGA are regulated by UDP-GlcNAc 
availability, protein-protein interactions, and posttransla-
tional modifi cations, but the precise mechanisms involved 
are poorly understood ( 18, 19 ). Of note, the sensitivity of 
OGT to glucose increases with decreasing insulin signaling 
( 20 ), whereas insulin mediates spatio-temporal activation 
of OGT, regulating substrate specifi city of the enzyme at 
the plasma membrane ( 21 ). 
 Several studies have shown that ChREBP is activated by 
glucose through a variety of glucose metabolites gener-
ated downstream of G-6-P, including xylulose-5-phosphate, 
fructose-6-phosphate, and fructose-2,6-bisphosphate ( 22 ). 
The mechanisms through which these glucose metabolites 
modulate ChREBP activity are unclear, but are believed to 
involve allosteric regulation and dephosphorylation of the 
canonical isoform ChREBP at Ser196 and Thr666 leading 
to its nuclear translocation and regulation of target gene 
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 Luciferase reporter assay 
 Huh7 cells were transfected with 150 ng of pGL3-basic-pChREBP-
Luc reporter plasmid (ChREBP  -prom), with 50 ng pcDNA3-
FLAG-hLXR  , pcDNA3-FLAG-hLXR  , pcDNA3-hRXR  , or empty 
pcDNA3 expression plasmid. pRL-CMV (Promega; 50 ng) was 
included as internal control to normalize for transfection effi -
ciency. All transfections were performed using Lipofectamine 2000. 
Dual-Luciferase reporter assay was performed 24 h posttransfec-
tion as previously described ( 34 ). For siRNA experiments, Huh7 
cells were transfected with 40 nM of siOGT or nontargeting 
siRNA. Posttransfection (24 or 48 h), the cells were further trans-
fected with pChREBP  -prom and pRL-CMV with pcDNA3-FLAG-
hLXR  , pcDNA3-hRXR  , and/or empty vector as described 
above in siRNA containing medium. Luciferase activity was mea-
sured after an additional 24 h. Transfections were verifi ed by im-
munoblotting using 20   l cell lysate and antibodies described 
below. 
 RNA extraction, cDNA synthesis, and quantitative RT-PCR 
 RNA was isolated with TRIZOL® reagent (Invitrogen) accord-
ing to the manufacturer’s protocol, including high salt precipita-
tion (0.8 M sodium acetate, 1.2 M NaCl) to avoid contaminating 
polysaccharides to coprecipitate with RNA. Isolated RNA was re-
verse transcribed into cDNA using a high-capacity cDNA Archive 
kit (Applied Biosystems). Analysis of mRNA expression was done 
by quantitative RT-PCR on a 7900HT instrument (Applied Bio-
systems). Gene expression was normalized against the expression 
of tata-binding protein (Tbp). Primers were as follows: TaqMan 
gene expression assays detecting mouse:  Acc  (Mm01304257_
m1),  Acc  (Mm01204678_m1), elongation of long-chain fatty acid 
family member 6 ( Elovl6 ) (Mm00851223_s1),  Fas (Mm00662319_
m1),  Gfat1 (Mm00600127_m1),  Gfat2 (Mm00496565_m1),  Gk 
(Mm00439129_m1), glycerol-3-phophate acyltransferase ( Gpat ) 
(Mm00833328_m1),  L-pk (Mm00443090_m1),  Ogt (Mm00507317_
m1),  Oga (Mm00452409_m1),  Scd1 (Mm00772290_m1),  tbp 
(Mm00446971_m1); or SYBR primers detecting mouse:  Chrebp  
(5 ′ -CGACACTCACCCACCTCTTC, 5 ′ -TTGTTCAGCCGGATCTT-
GTC) ( 28 ),  Chrebp  (5 ′ -TCTGCAGATCGCGTGGAG, 5 ′ -CTT-
GTCCCGGCATAGCAAC) ( 28 ),  Lxr  (5 ′ -GGAGTGTCGACTTC-
GCAAATG, 5 ′ -CAGCACACACTCCTCCCTCA),  Lxr  (5 ′ -GCTCT-
GCCTACATCGTGGTCA, 5 ′ -TGCGCTCAGGCTCATCCT),  Mlx 
(5 ′ -GGAGCTCTCAGCTTGTGTCTTCA, 5 ′ -CACCGATCACAAT-
CTCTCGTAGAGT) ( 28 ),  Srebp-1 (5 ′ -GGAGCCATGGATTGCA-
CATT, 5 ′ -GCTTCCAGAGAGGAGGCCAG) ( 35 ). 
 Generation of LXR antibody 
 Rat LXR  and LXR  proteins were purifi ed as described pre-
viously ( 36 ). Rabbits were immunized at Agisera (Vännäs, Sweden) 
by a standard immunization program. Briefl y, 0.25 mg of LXR  and 
LXR  were injected four times and serum collected after 15 weeks. 
Purifi ed LXR  and LXR  protein (1.4 mg) in 0.2 M NaHCO 3 , 
0.5 M NaCl (pH 8.3) buffer were coupled on a HiTrap NHS-
activated matrix column (GE Healthcare). The immunized rabbit 
serum was added to the column and washed according to stan-
dard procedure. Elution of anti-LXRs was performed 10 times 
and eluates were pooled. 
 Liver extracts and immunoblot analysis 
 Nuclear and cytoplasmic proteins were prepared using the 
NE-PER extraction kit (Pierce Biotechnology) with the follow-
ing inhibitors added to the buffers: 1 mM NaF, 1 mM Na 3 VO 4 , 
1 mM   -glycerophosphate, 1   M O-GlcNAcase inhibitor GlcNAc-
thiazoline, and CompleteTM protease inhibitors (Roche Applied 
Science). Proteins were separated by SDS-PAGE (Bio-Rad) and 
blotted onto polyvinylidene difl uoride membrane (Millipore ). 
Glucose-free DMEM (11966-025), TRIzol® reagent (15596-018), 
UltraPure™ phenol:chloroform:isoamyl alcohol (15593-031), and 
isopropylthio-  -galactoside (IPTG) (15529-019) were from Invit-
rogen. Silencing RNA targeting OGT (ON-TARGET Plus SMART 
Pool, catalog number L-019111-00) and scrambled control siRNA 
(ON-TARGET Plus® Control Pool, catalog number D-001818-10-
05) were from Thermo Scientifi c Dharmacon. Dual-Luciferase® 
reporter assay system (E194A) was from Promega. All other 
chemicals were of the highest quality available from commercial 
vendors. 
 Plasmids 
 LXR  /  cDNA in plasmids pcDNA3-FLAG-hLXR  and 
pcDNA3-FLAG-hLXR  , previously described ( 15 ), were subcloned 
into pGEX-4T-1 or pEGFP vectors . The generation of pcDNA3-
hRXR  has been described previously ( 29 ). pET-24b-His-ncOGT 
was a kind gift from Suzanne Walker ( 30 ). The pCAG-HA-OGT 
and the pCherry-OGT plasmids were kind gifts from Gerald Hart. 
The pGL3-basic and pGL3-basic-pChREBP (ChREBP  -prom) 
reporter plasmids were kindly provided by Karine Gauthier Vana-
cker ( 31 ). Sequences were verifi ed by DNA sequencing. 
 Animals and treatment 
 Male LXR   -defi cient (LXR   /   ) mice and wild-type litter-
mates (LXR +/+ ) were housed in a temperature-controlled (22°C) 
facility with a strict 12 h light/dark cycle. The mice had free ac-
cess to food and water at all times. LXR   /   mice and correspond-
ing controls had mixed genetic background based on 129/Sv 
and C57BL/6J strains, backcrossed in C57BL/6J for at least six 
generations. The generation of the LXR   /   mice has been de-
scribed previously ( 32, 33 ). STZ was prepared in a sodium citrate 
buffer (50 mmol/l, pH 4.5) immediately before injections. STZ-
treated mice were treated with two intraperitoneal injections of 
STZ (100 mg/kg) with a 1 day interval. Seven days after the fi rst 
STZ injection, mice were included in a fasting-refeeding experi-
ment with matched untreated control mice. Mice were fasted for 
24 h or fasted for 24 h and refed for 12 h on a diet containing 
64% carbohydrates, 31.5% protein, 4.5% fat, and no cholesterol 
(SDS RM no.1 maintenance, Special Diets Services, UK). The 
mice were euthanized by cervical dislocation at 8:00 AM and tis-
sues were weighed and snap-frozen in liquid nitrogen and stored 
at   80°C until further analysis. All use of animals was approved 
and registered by the Norwegian Animal Research authority. 
 Blood chemistries and liver lipid analyses 
 Blood glucose was measured at the time of euthanization with 
a handheld glucometer (Roche). Serum was separated from 
blood by centrifugation. Serum insulin was measured using the 
ultra-sensitive insulin kit from Mercodia (Mercodia AB, Uppsala, 
Sweden) according to the manufacturer’s instructions. Serum 
lipid quantifi cation, using enzymatic in vitro tests, was done on a 
Roche Hitachi 917. TGs were determined with a TG GPO-PAP kit 
(11730711216; Roche). Liver samples were homogenized in cold 
sucrose buffer [0.25 M sucrose, 10 mM HEPES, 1 mM Na-EDTA 
(pH 7.4)] and centrifuged at 600  g for 10 min at 4°C and hepatic 
TGs were measured in the supernatant using the TG GPO-PAP 
kit according to the manufacturer’s protocol. 
 Cells cultures and transfections 
 Huh7 liver hepatoma cells were maintained in high glucose 
(25 mM) DMEM (D6546) or adapted to physiological glucose 
(5 mM) DMEM (D6046) supplemented with 10% fetal bovine 
serum, 4 mM  L -glutamine, and 1% penicillin-streptomycin. Cells 
were transfected with Lipofectamine 2000 before luciferase re-
porter assay, immunofl uorescence, and immunoprecipitation, as 
described in the sections below. 
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( 30 ). For GST pulldown assays, lysates were incubated with gluta-
thione Sepharose 4B beads (GE Healthcare), washed six times 
[10 mM TrisHCl (pH 7.5), 150 mM NaCl, 0.5 mM EDTA, 0.5% 
NP-40], proteins were then eluted by boiling in 2× Laemmli buf-
fer and separated by SDS-PAGE. Precipitated proteins were de-
tected by immunoblotting. 
 Succinylated wheat germ agglutinin pulldown 
 Nuclear extracts (100   g) were incubated with protein A/G-
agarose beads (sc-2003; Santa Cruz Biotechnology) for 1 h at 4°C. 
Cleared extracts were transferred to new tubes and incubated 
with 30   l of succinylated wheat germ agglutinin (sWGA)-agarose 
(Vector Lab) with or without 0.5 M GlcNAc overnight at 4°C. 
After four washes (PBS, 0.2% NP-40), proteins were eluted from 
the beads in 2× Laemmli buffer and separated by SDS-PAGE. The 
captured proteins were analyzed by immunoblotting. 
 Immunofl uorescence 
 Huh7 cells were seeded on coverslips (2.5 × 10 5 cells/cover-
slip) and transfected with 200 ng pEGFP-LXR  or pEGFP-LXR  
and 800 ng pCherryOGT 24 h after seeding. Twenty-four hours 
after transfection, cells were treated with DMSO (0.1% fi nal) or 
1   M GW3965 for 2 h by addition of ligand directly to culture 
media and cells were then fi xed in 4% paraformaldehyde and 
permeabilized with 0.4% Triton X-100 for 20 min. Fixed cells 
were counterstained with 4,6-diamidino-2-phenylindole (DAPI) 
and mounted with Vectashield (Vector Laboratories). Images 
were acquired at 60× magnifi cation using an Olympus FluoView 
1000 confocal microscope. 
 Coimmunoprecipitation 
 Huh7 cells were transfected with 1   g pCAG-HA-OGT and 
0.5   g pcDNA3-FLAG-LXR  or pcDNA3-FLAG-LXR  . Cells were 
washed twice with cold PBS and harvested in lysis buffer [200 mM 
NaCl, 20 mM HEPES (pH 7.4), 1% NP-40] containing 1 mM 
NaF, 1 mM Na 3 VO 4 , 1 mM   -glycerophosphate, 1   M O-GlcNA-
case inhibitor GlcNAc-thiazoline, and CompleteTM protease in-
hibitors (Roche Applied Science). The lysate was cleared by 
centrifugation and the supernatants were immunoprecipitated 
with 2   g FLAG M2, 2   g OGT (AL28), and mouse IgG antibody 
(015-000-002; Jackson Laboratory) bound to protein G Dyna-
beads (Invitrogen) for 4 h at 4°C. Beads were washed three times 
in wash buffer [200 mM NaCl, 20 mM HEPES (pH 7.4), 0.1% 
NP-40] and proteins were eluted from the beads with 1× Nu-
PAGE LDS sample buffer (Invitrogen) at 70°C for 10 min. Coim-
munoprecipitated proteins were analyzed by immunoblotting 
with FLAG M2 or OGT antibodies. Liver was homogenized in ly-
sis buffer with inhibitors and lysate was cleared by centrifugation 
for 10 min. Cleared lysates (500   g) were immunoprecipitated 
with 3   g antibody against LXR, OGT (AL28), or rabbit IgG 
(011-000-002; Jackson Laboratory) bound to protein G Dyna-
beads (Invitrogen). Coimmunoprecipitated proteins were ana-
lyzed by immunoblotting. 
 Statistical analysis 
 Statistical analyses were performed using SPSS 22 (IBM Corp.). 
All data are presented as means and SEM, and error bars for all 
results are derived from biological replicates rather than techni-
cal replicates. The homogeneity of variances between groups was 
evaluated using Levene’s test. If signifi cant, a Welch test was ap-
plied to assess overall differences combined with a Dunnett’s T3 
post hoc test to establish intergroup comparisons. If Levene’s test 
was not signifi cant and homogeneity of variances could be as-
sumed, statistical differences between groups were determined 
by one-way ANOVA followed by Tukey’s multiple comparison 
tests.  P < 0.05 was considered statistically signifi cant. 
Primary antibodies used were rabbit anti-mouse LXR (1:500) (see 
generation of antibodies), retinoid X receptor (RXR)  (1:1,000) 
(sc-553; Santa Cruz Biotechnology), ChREBP (1:1,000) (NB400-
135; Novus Biologicals), FAS (1:500) (sc-55580; Santa Cruz Biotech-
nology), SCD1 (1:2,000) (sc-14719; Santa Cruz Biotechnology), 
  -tubulin (1:20,000) (T5168; Sigma-Aldrich), lamin A (1:1,000) 
(L1293; Sigma-Aldrich), GFAT1/2 (1:3,000) ( 37 ), GFAT2 (1:1,000) 
(sc-134710; Santa Cruz Biotechnology), OGT (1:1,000) (AL28) 
( 38 ), CTD110.6 (1:2,500) (MMS-248R; Covance), SREBP-1 (1:1,000) 
( 39 ), L-PK (1:2,000) (MABS148; Merck Millipore), FLAG M2 
(1:10,000) (F1804; Sigma-Aldrich), GK (1:2,000) ( 40 ), and gluta-
thione-S-transferase (GST)- HRP (ab58626; Abcam). Secondary 
HRP-conjugated anti-mouse, 115-035-174; anti-rabbit, 211-032-
171; anti-sheep, 713-035-003 (all from Jackson ImmunoResearch 
Laboratories); anti-goat, 605-4302 (Rockland) antibodies were 
used at 1:10,000 dilutions. Anti-mouse IgM (A8786; Sigma) was 
used at a 1:5,000 dilution. Clean-Blot IP detection reagent (HRP) 
(PIER21230, Pierce) was used at 1:1,000. 
 Chromatin immunoprecipitation 
 Chromatin immunoprecipitation (ChIP) experiments were 
performed as described previously ( 41 ). Briefl y, liver tissue was 
cross-linked with 1% formaldehyde for 10 min at room tempera-
ture. Cross-linking was stopped by 10 min incubation with 12.5 mM 
glycine. Samples were washed twice in cold PBS and harvested in 
lysis buffer [0.1% SDS, 1% Triton X-100, 0.15 M NaCl, 1 mM 
EDTA, and 20 mM Tris (pH 8.0)]. Lysed tissue was sonicated us-
ing a Bioruptor (Diagenode) to an average size of 200–500 bp 
fragments. Chromatin was immunoprecipitated with 2   g anti-
body against LXR, ChREBP (NB400-135; Novus Biologicals), or 
rabbit IgG (011-000-002; Jackson Laboratory). Sepharose beads 
(GE Healthcare) were washed three times in lysis buffer, incu-
bated with BSA (1   g/  l) for 3 h, added to the chromatin and 
left to rotate at 4°C overnight. Beads were washed twice with buf-
fer 1 [0.1% SDS, 0.1% deoxycholic acid (DOC), 1% Triton 
X-100, 0.15 M NaCl, 1 mM EDTA, 20 mM HEPES (pH 7.6)]; once 
in buffer 2 [0.1% SDS, 0.1% DOC, 1% Triton X-100, 0.5 M NaCl, 
1 mM EDTA, 20 mM HEPES (pH 7.6)], once in buffer 3 [0.25 M 
LiCl, 0.5% DOC, 0.5% Nonidet P-40, 1 mM EDTA, 20 mM HEPES 
(pH 7.6)], and twice in buffer 4 [1 mM EDTA and 20 mM HEPES 
(pH 7.6)]. All washing steps were done for 5 min at 4°C. DNA-
protein complexes were eluted with 1% SDS and 0.1 M NaHCO 3 
and reverse cross-linked by adding 0.2 M NaCl and overnight in-
cubation at 65°C. DNA was purifi ed by phenol-chloroform ex-
traction, precipitated in ethanol with sodium acetate, and dis-
solved in water. DNA enrichment was quantifi ed by quantitative 
RT-PCR. ChIP PCR primers spanning mouse LXR response ele-
ments (LXREs) were designed to amplify known LXR-enriched 
regions ( 41 ) and were as follows:  Srebp-1 LXRE (5 ′ -CAGAACTT-
GCCTGGACCATT, 5 ′ -AAATCTTGCTGCTGCCATTC),  Chrebp 
LXRE (5 ′ -CGTTCAATCTCTGTGGATCGT, 5 ′ -AAGTGGCCT-
GATTCACCTCT),  Gk LXRE (5 ′ -CATTCTGGGCTCTTCTACGG, 
5 ′ -TGCAGAGTATGTTGGGGTCA),  Fas LXRE (5 ′ -GGGTTAC-
TACCGGTCATCGT, 5 ′ -CCGTCAGTGTTCCCTATCCT);  Scd1 
LXRE (5 ′ -AAGTGCATTGCTGAGACTTCC, 5 ′ -CCTCCACAGCC-
TCTTTGTCT). The binding of ChREBP to the ChORE in the 
promoter-proximal enhancer of  L-pk has been described previ-
ously ( 25 ) and was as follows:  L-pk ChORE (5 ′ -GTCCCACACTT-
TGGAAGCAT, 5 ′ -CCCAACACTGATTCTACCC). 
 Recombinant proteins and GST pulldown 
 pET-24b-His-ncOGT, pGEX-4T-1-hLXR  , and pGEX-4T-1-
hLXR  were expressed in  Escherichia coli BL21 (DE3) Star (Invit-
rogen). Human His-ncOGT was grown and purifi ed as previously 
described ( 30 ). GST fusion proteins were expressed as described 
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different between genotypes in refed control mice, but were 
almost abolished (70% lower in cytosolic, 90% lower in 
nuclear) in refed LXR   /   STZ-treated hyperglycemic mice 
compared with refed LXR +/+ mice treated with STZ ( Fig. 
1C ; band intensity quantifi cations relative to loading con-
trol using Image J software). This suggests that transcrip-
tional and posttranscriptional regulation of ChREBP  is 
dependent on LXR under hyperglycemic conditions lack-
ing the postprandial insulin signal. ChREBP  is believed 
to be retained inactive in the cytoplasm during fasting 
( 23 ). Our observed nuclear localization of ChREBP in the 
fasted state may refl ect levels of the constitutively nuclear 
localized ChREBP  ( 25 ). However, we were not able to 
distinguish between the two isoforms in Western blotting 
analysis (ChREBP  , 93 kDa; ChREBP  , 90 kDa). Further-
more, we did not observe a signifi cant fasting-refeeding 
shuttling of ChREBP between the cytosolic and nuclear 
compartments. Rather, cytosolic and nuclear ChREBP 
protein levels were comparable under each condition. 
ChIP assays revealed increased LXR recruitment to an 
LXRE in the  ChREBP  promoter in refed control and STZ-
treated mice. LXR recruitment to an LXRE in the  SREBP-1 
promoter was evident in refed control mice, but only a 
weak nonsignifi cant increase in LXR binding was observed 
in STZ-treated mice ( Fig. 1D ), which did not refl ect the 
strong induction of  Srebp-1c mRNA levels in these mice 
( Fig. 1B ). This may be due to increased coactivator recruit-
ment to this LXRE and/or increased SREBP-1c autoregu-
lation under hyperglycemic conditions. Taken together, 
these data suggest that LXRs are essential regulators of 
SREBP-1 and ChREBP expression also in the absence of 
postprandial insulin. 
 Expression of hepatic de novo lipogenic genes and 
production of plasma TGs through LXR are not 
dependent on insulin signaling 
 We next investigated the expression of genes down-
stream of the LXR lipogenic axis to further delineate the 
effects of hyperglycemic conditions on LXR activity. A sche-
matic representation of DNL with the proteins involved is 
provided in  Fig. 2A .  Gk and  L-pk mRNA levels were induced 
approximately 50-fold and 6-fold in refed control mice, re-
spectively ( Fig. 2B ). These genes were also signifi cantly 
upregulated in refed STZ-treated mice; however, the level 
of induction was less than that observed in control mice 
(10-fold for  Gk , 3-fold for  L-pk ). Of note, expression of 
gluconeogenic genes, glucose-6-phosphatase and phospho-
enolpyruvate carbokinase ( PEPCK ), and the gluconeogenic 
coactivator peroxisome proliferator-activated receptor   
coactivator 1-  ( PGC1  ) were strongly downregulated in 
both control and STZ-treated mice (data not shown), 
supporting increased G-6-P synthesis above fasting levels 
in hyperglycemic STZ-treated mice. In support of our 
observations, others have shown downregulation of glu-
cose-6-phosphatase and PEPCK in response to glucose and 
sucrose refeeding in control and STZ-treated mice ( 13, 43 ). 
Moreover, GLUT2 expression is increased in refed STZ-
administered mice, ensuring increased hepatic glucose up-
take in hyperglycemia ( 43 ). The mRNA levels of  Fas ,  Elovl6 , 
 RESULTS 
 Feeding induces LXR  protein levels 
 To examine the effects of insulin on LXR-regulated he-
patic lipogenic target gene expression, LXR +/+ and LXR   /   
control and STZ-treated mice were placed on a fasting-
refeeding regime. STZ was used to destroy pancreatic   -
cells and insulin production. Using this model, the effect of 
insulin could be distinguished from those of hyperglycemia 
in refed STZ-treated mice (low insulin, high glucose) com-
pared with untreated control mice (high insulin, high glu-
cose). In hepatocytes expressing the insulin-independent 
low-affi nity glucose transporter, GLUT2, glycolysis is fa-
vored in the fed state when glucose is abundant ( 42, 43 ). 
LXR +/+ and LXR   /   refed control mice showed increased 
serum insulin and blood glucose levels, whereas refed STZ-
treated mice were hyperglycemic with fasting insulin levels 
( Fig. 1A ). Insulin levels were slightly, but not signifi cantly, 
higher in fed LXR +/+ compared with LXR   /   control mice, 
supporting the known role of LXR in glucose homeostasis, 
insulin secretion, and pancreatic function ( 44, 45 ). No sig-
nifi cant differences in body weight or liver weight were 
found between treatment-matched LXR +/+ and LXR   /   
mice (supplementary Table 1).  Lxr  and  Lxr  mRNA 
expression levels were unaffected in refed control and 
STZ-treated LXR +/+ mice when compared with treatment-
matched fasted mice ( Fig. 1B ). Nuclear LXR  protein levels 
were 2.1- to 2.5-fold increased in refed control and STZ-
treated mice ( Fig. 1C ; band intensity quantifi cations relative 
to loading control using Image J software), whereas LXR  
protein levels remained unchanged. These data suggest 
that feeding increases LXR  protein expression via post-
transcriptional or posttranslational mechanisms in vivo. 
 LXR confers differential regulation of hepatic ChREBP 
isoform expression 
 The expression and activity of SREBP-1c and ChREBP 
are regulated by insulin and glucose ( 43, 46 ). Because 
SREBP-1c and ChREBP can work in concert with LXRs to 
regulate hepatic lipogenic genes ( 5, 6, 47 ), we investigated 
the expression of SREBP-1 and ChREBP upon refeeding 
under normal and hyperglycemic insulin-independent 
conditions. In agreement with previous reports,  SREBP-1c 
mRNA and protein levels were strongly induced in refed 
control and STZ-treated LXR +/+ mice ( Fig. 1B, C ) ( 15, 43 ) 
and almost completely abolished in LXR   /   mice ( 26, 47 ). 
 Chrebp  mRNA expression was elevated (2-fold) by refeed-
ing in LXR +/+ control and STZ-treated mice and this in-
duction was signifi cantly lower in LXR   /   mice. However, 
a 1.4-fold induction in  Chrebp  mRNA levels was observed 
in control LXR   /   mice (no induction in STZ-treated 
LXR   /   mice) ( Fig. 1B ). Expression levels of the newly 
identifi ed shorter isoform,  Chrebp  ( 28 ), were strongly in-
duced by refeeding in both control and STZ-treated mice 
(6-fold), and almost abolished in LXR   /   mice. Interest-
ingly, ChREBP cytosolic and nuclear protein levels, de-
tected by immunoblotting with an antibody recognizing 
ChREBP  as well as ChREBP  (our own observations 
in ChREBP  overexpressing cells), were not statistically 
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 Fig.  1. LXRs confer differential regulation of hepatic ChREBP isoform expression. C57BL/6 control and STZ-treated male mice were 
fasted (white bars) or fasted-refed for 12 h (black bars). A: Insulin and glucose levels. B: Hepatic gene expression of Lxr  /  , Srebp-1, Mlx, 
and Chrebp  /  was analyzed by quantitative RT-PCR and normalized to Tbp. C: Nuclear lysates were subjected to SDS-PAGE and immu-
noblotted with antibodies against LXR, SREBP-1, and ChREBP. Cytosolic levels of SREBP-1 and ChREBP are also shown.   -Tubulin and 
lamin A were used as controls for cytosolic and nuclear fractions, respectively. Each lane represents independent mice from experimental 
groups. The samples for control and STZ-treated mice were loaded on separate gels and the fi lms were developed with the same exposure 
time. One representative Western blot is shown (n = 2). D: LXR binding to LXRE-containing promoter regions of  SREBP-1c and  ChREBP 
were analyzed by ChIP with antibody recognizing LXR  /  . All values are mean ± SEM (n = 4–5). * P < 0.05, ** P < 0.01, *** P < 0.001 com-
pared with fasted within experimental groups.  # P < 0.05,  ## P < 0.01,  ### P < 0.001 compared with refed within STZ treatment . 
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 Fig.  2. Expression of hepatic de novo lipogenic genes and production of plasma TGs through LXR are not dependent on insulin signal-
ing. A: Simplifi ed schematic overview of the genes involved in hepatic DNL. B: Hepatic gene expression was analyzed by quantitative RT-
PCR and normalized to Tbp. C: Cytosolic lysates were immunoblotted with antibodies against GK, L-PK, FAS, and SCD1 with   -tubulin as 
loading control. Each lane represents independent mice from experimental groups. The samples for control and STZ-treated mice were 
loaded on separate gels and fi lms were developed with the same exposure time, unless otherwise indicated. D: LXR binding at the LXRE-
containing promoter regions of  GK ,  FAS , and  SCD1 were analyzed by ChIP experiments with antibody recognizing LXR  /  . E: Liver and 
plasma TGs. All values are given as mean ± SEM (n = 4–5). * P < 0.05, ** P < 0.01, *** P < 0.001 compared with fasted within experimental 
group.  # P < 0.05,  ### P < 0.001 compared with refed within control or STZ treatment. ns, not signifi cant. 
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LXR  /RXR  transfected cells after high glucose (25 mM) 
compared with low glucose (1 mM) treatment for 24 h 
( Fig. 3B ). To determine whether OGT-mediated O-GlcNAc 
signaling was conferring the glucose effect on ChREBP  
expression through LXR  , Huh7 cells, cultured in physi-
ological (5 mM) and high glucose, were transfected with 
scrambled siRNA or siRNA against OGT. One to two 
days after siRNA transfection, cells were transfected with 
LXR  /RXR  and  ChREBP  promoter construct in siRNA-
containing medium and cells were analyzed for luciferase 
activity the following day. The stimulating effect of high 
glucose through LXR  was approximately 30% reduced in 
siOGT-transfected cells, whereas no signifi cant reduction 
was observed under normoglycemic (5 mM) conditions 
( Fig. 3C ), arguing for a role for OGT signaling in high 
glucose/LXR-mediated transactivation of the  ChREBP  
promoter. 
 LXR regulates nuclear O-GlcNAc signaling 
 Having established a role for LXR in mediating glucose 
responses on the promoters of ChREBP  and SREBP-1c 
( 15 ) via HBP/O-GlcNAc signaling, we next investigated the 
impact of feeding and LXR on expression of central genes 
in this pathway ( Fig. 4A ). Expression levels of GFAT1, the 
rate limiting enzyme of HBP, was upregulated by feeding in 
the absence and presence of insulin, whereas the less char-
acterized isoform, GFAT2, was only upregulated in STZ-
treated mice (3-fold) and more so in LXR   /   mice (6-fold), 
suggesting a possible negative feedback by LXRs on GFAT2 
expression under hyperglycemic conditions. GFAT1, but 
not GFAT2, was localized in both cytoplasmic and nuclear 
fractions in LXR +/+ and LXR   /   mice, suggesting a possible 
nuclear production of glucosamine-6-phosphate, an inter-
mediary product in the HBP generating UDP-GlcNAc, the 
substrate for OGT ( Fig.4B ). Hepatic UDP-GlcNAc concen-
trations have been previously shown to be increased by 
approximately 60% in ad libitum-fed STZ-treated rats 
compared with controls ( 49 ). OGT and OGA expression 
were not regulated by feeding or LXR ( Fig. 4A, B ). Surpris-
ingly, nucleocytoplasmic OGT protein expression was unaf-
fected ( Fig. 4B ), but nuclear protein O-GlcNAcylation was 
signifi cantly lower in refed LXR   /   mice under both con-
trol and hyperglycemic conditions ( Fig. 4C ), suggesting 
that LXR, by direct or indirect mechanisms, regulates nu-
clear OGT activity. In line with our observations in vivo, 
LXR potentiated nuclear, but not cytosolic, protein O-
GlcNAcylation in LXR-tranfected Huh7 cells compared 
with empty vector controls (data not shown). Cytosolic pro-
tein O-GlcNAcylation was not affected by LXR defi ciency as 
revealed by Western blotting analysis using a pan-O-GlcNAc-
specifi c antibody (CTD 110.6), and total nuclear and cyto-
solic protein O-GlcNAcylation levels were similar in control 
and STZ-treated mice ( Fig. 4C ). 
 LXRs regulate O-GlcNAcylation of ChREBP and binding 
of ChREBP  to the  L-pk promoter 
 Recently, O-GlcNAcylation of ChREBP was shown to po-
tentiate its activity, stability, and binding to the promoter-
proximal enhancer of  L-pk ( 25 ). Based on that study and 
 Acc  , and  Gpat were elevated to a similar degree in both 
refed control and STZ-treated mice. Notably, the mRNA 
levels of  Acc  and  Scd1 were highly induced in LXR +/+ STZ-
treated mice, where SREBP-1c may be important ( 43 ). In-
terestingly, GK and L-PK protein levels did not mimic the 
induced mRNA expression levels in refed LXR +/+ mice, 
there were only small insignifi cant changes, which could be 
due to posttranslational regulation of the active proteins 
( Fig. 2C ). GK protein levels were 1.4 times higher in refed 
control compared with fasted control LXR +/+ mice and 1.6 
times higher in refed STZ compared with fasted STZ 
LXR +/+ mice. Fasting GK protein levels were 2.8 times 
higher in fasted control compared with fasted STZ mice 
and GK and L-PK levels were signifi cantly lower in refed 
LXR   /   mice compared with LXR +/+ mice in both control 
(GK 50% lower, L-PK 92% lower) and STZ-treated mice 
(GK 65% lower, L-PK 77% lower) ( Fig. 2C ; band intensity 
quantifi cations relative to loading control using Image J 
software). LXR binding to the LXREs in the promoters of 
 Gk ,  Fas , and  Scd1 was signifi cantly induced in refed control 
mice, but LXR binding was only signifi cantly induced to 
the  Scd1 LXRE in STZ-treated mice ( Fig. 2D ). Differences 
may be due to alternative LXREs in promoters or enhanc-
ers of these genes, and/or coregulator interactions. The 
induction of lipogenic genes was followed by increased 
plasma TGs in refed control and STZ-treated LXR +/+ , but 
not LXR   /   , mice ( Fig. 2E ). Plasma nonesterifi ed fatty ac-
ids and cholesterol were not statistically different between 
LXR +/+ and LXR   /   mice (data not shown). Similar to pre-
vious reports, LXR   /   mice accumulated fewer hepatic 
TGs compared with LXR +/+ littermates, and in STZ-treated 
compared with control mice ( 43, 48 ) ( Fig. 2E ). No differ-
ences in expression of hepatic fatty acid oxidation genes 
( Cpt1 and  Acox1 ) or genes involved in endoplasmic reticu-
lum stress ( Hspa5 ,  Hsp90b1 , and  Calr ) were observed, sug-
gesting that the lower hepatic TG content was independent 
of these pathways (data not shown). Taken together, our 
fi ndings suggest that LXR regulates hepatic lipogenic genes 
and TG content under hyperglycemic conditions indepen-
dently of insulin, suggestive of a role for glucose in regulat-
ing LXR activity as previously suggested ( 13, 15 ). 
 High glucose regulates LXR transactivation of the 
 ChREBP  promoter via O-GlcNAc 
 We have previously reported increased O-GlcNAcylation 
of LXR in vivo and in vitro in response to refeeding and 
high glucose treatment contributing to increased  SREBP-
1c promoter activation ( 15 ). To examine whether high 
glucose can regulate the  ChREBP  promoter through 
LXRs, Huh7 cells were cotransfected with LXR  or LXR  
and/or RXR  expression vectors together with a lucifer-
ase reporter construct containing 3.2 kb of the 5 ′ -fl anking 
region of the mouse  ChREBP  promoter ( Fig. 3A, B ). Co-
transfected with RXR  , LXR  conferred an approximately 
30-fold induction of  ChREBP  promoter-luciferase activity 
as compared with 8-fold by LXR  in Huh7 cells adapted to 
high glucose (25 mM) ( Fig. 3A ). Moreover, in cells adapted 
to physiological glucose levels (5 mM), we observed a 
30% increase in ChREBP  promoter-luciferase activity in 
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the reduced L-PK expression and protein O-GlcNAc levels 
observed in LXR   /   mice, we investigated whether LXR 
could regulate ChREBP activity through modulating O-
GlcNAcylation of ChREBP. Using lectin (sWGA) pulldown 
experiments, we observed lower levels of O-GlcNAcylated 
proteins precipitated from nuclear lysates isolated from 
refed LXR   /   mice compared with LXR +/+ controls, which 
was in agreement with reduced total protein O-GlcNAc 
( Fig. 5A ). Specifically, ChREBP O-GlcNAcylation was 
strongly reduced in refed LXR   /   mice compared with 
LXR +/+ mice as determined by 83 and 73% reduced recovery 
of ChREBP protein after sWGA pulldown in control and 
STZ-mice, respectively ( Fig. 5A ; band intensity quantifi ca-
tion using Image J software). As expected and in line with 
our previous observations ( 15 ), LXR  was strongly recov-
ered on sWGA beads in refed liver, whereas LXR  was re-
covered under both fasted and refed conditions, suggestive 
of postprandial glucose-O-GlcNAc sensing via LXR  . 
SREBP-1 was not recovered on sWGA beads, suggesting 
that SREBP-1 is not a target for O-GlcNAc modifi cation 
(data not shown). In ChIP assays, recruitment of ChREBP 
to its cognate DNA-binding site in the  L-pk promoter was 
signifi cantly higher in refed control compared with fasted 
mice ( Fig. 5B ), consistent with hepatic  L-pk mRNA expres-
sion ( Fig. 2B ). Interestingly, ChREBP was not recruited 
to  L-pk in control livers of LXR   /   mice despite high 
ChREBP  protein expression, suggesting that ChREBP  is 
essential for ChREBP-dependent target gene activity in re-
sponse to feeding in the presence of postprandial insulin 
signaling. Although ChREBP binding to the  L-pk promoter 
was increased in the liver of refed STZ-treated mice ( Fig. 
5B ),  L-pk mRNA was only modestly increased ( Fig. 2B ), 
suggesting that the insulin signal is potentiating ChREBP  
and/or ChREBP  transactivation on the  L-pk promoter. 
 LXR interacts and colocalizes with OGT in vitro 
and in vivo 
 Prompted by our observations that LXRs are targets for 
O-GlcNAc modifi cation ( 15 ) and appear to potentiate nu-
clear O-GlcNAc signaling without affecting expression of 
 GFAT1/2 ,  OGT , or  OGA , we performed immunofl uores-
cence and coimmunoprecipitation experiments to deter-
mine a possible colocalization and/or interaction of LXRs 
and OGT. Ectopically expressed cherry-OGT and EGFP-
LXR  or EGFP-LXR  colocalized in the nucleus of Huh7 
cells treated with DMSO or GW3965, a synthetic LXR 
 Fig.  3. High glucose regulates LXR transactivation of the  ChREBP  
promoter via O-GlcNAc. A: Huh7 cells maintained in 25 mM 
glucose were transfected with ChREBP  - Firefl y luciferase reporter 
(ChREBP  -prom),  Renilla luciferase control plasmid (pRL-CMV) 
and RXR  expression vector and/or LXR  or LXR  expression 
vectors or empty vector (pcDNA3.1) (n = 3). Dual luciferase assay 
was performed and lysates were immunoblotted with antibodies 
against FLAG, RXR  , and   -actin as loading control. A schematic 
fi gure of the ChREBP  reporter construct (ChREBP  -prom) in-
cluding the two LXREs is shown. B: Huh7 cells maintained in 5 mM 
glucose were transfected with ChREBP  -prom or pGL3-Basic with 
empty expression vector or RXR  and LXR  expression vectors. 
All transfections contained pRL-CMV. After 6 h, the cells were 
treated with 1 mM or 25 mM glucose for 24 h (n = 3). Dual lucifer-
ase assay was performed and lysates were subjected to SDS-PAGE 
and immunoblotted with an antibody detecting O-GlcNAc epitopes 
on proteins (CTD 110.6) with   -actin as loading control. One rep-
resentative Western blot is shown (n = 3). C: Huh7 cells maintained 
in 5 mM glucose (upper panel) and 25 mM glucose (lower panel) 
were transfected with 40 nM siRNA, nontargeting pool (siSrc), 
or human OGT (siOGT). After 24 h (25 mM glucose) and 48 h 
(5 mM glucose) the cells were further transfected with ChREBP  -
prom, pRL-CMV with empty vector, or RXR  and LXR  expres-
sion vectors. Dual luciferase assay was performed after another 24 h. 
Lysates were subjected to SDS-PAGE and immunoblotted with anti-
bodies against OGT, O-GlcNAc (CTD 110.6), LXR  , and RXR  
and   -actin as loading control (n = 3). All values are given as mean ± 
SEM. Statistical differences are shown as * P < 0.05 or *** P < 0.001 
between respective controls or as  ### P < 0.001 between indicated 
groups . 
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 DISCUSSION 
 LXRs regulate genes involved in hepatic fatty acid syn-
thesis in response to synthetic and endogenous ligands 
and insulin ( 50 ). In addition to being a substrate for lipo-
genesis, glucose has emerged as a lipogenic signal ( 2 ) that 
activates LXR ( 13, 15 ), ChREBP ( 22 ), and SREBP-1c ( 43 ). 
In contrast to SREBP-1c, ChREBP expression and activity 
is seemingly unaffected by LXR defi ciency in refed mice 
when both postprandial insulin and glucose signals are 
present ( 26 ). Pharmacological activation of LXR induces 
hepatic ChREBP expression ( 6, 41 ); however, whether 
LXR regulates ChREBP and de novo lipogenic gene expres-
sion in vivo under physiological conditions has not been 
fi rmly established ( 26, 27 ). 
agonist ( Fig. 6A ). However, colocalization of LXRs and 
OGT was independent of ligand treatment (GW3965) or 
glucose concentration in the culture medium (5 mM vs. 
25 mM) (data not shown). By GST pulldown experiments, 
we show that OGT and LXRs also interacted in a bacterial 
GST-LXR  /  /His-OGT coexpressed system, suggesting a 
direct interaction between OGT and LXRs ( Fig. 6B ). Fi-
nally, using a reciprocal coimmunoprecipitation strategy, 
we observed coimmunoprecipitation of OGT and LXRs in 
Huh7 cells cotransfected with HA-OGT and FLAG-LXR  
or FLAG-LXR  ( Fig. 6C ) and in the liver of fed wild-type 
mice ( Fig. 6D ). The interaction between OGT and LXRs 
in Huh7 cells was not affected by GW3965 (data not 
shown), suggesting that LXR interacts with OGT, indi-
rectly or directly, via its N-terminal domain. 
 Fig.  4. LXR regulates nuclear O-GlcNAc signaling. A: Hepatic gene expression of enzymes involved in HBP was analyzed in fasted (white 
bars) and refed (black bars) mice by quantitative RT-PCR and normalized to Tbp. B: Liver lysates from cytosolic (Cyt) and nuclear (NE) 
compartments were immunoblotted with antibodies against OGT, GFAT1/2, and GFAT2.   -Tubulin and lamin A were used as controls for 
Cyt and NE fractions, respectively. Each lane represents lysate from independent mice from each experimental group. A representative 
Western blot is shown (n = 2). C: Cytosolic and nuclear liver lysates were immunoblotted with anti-O-GlcNAc antibody (CTD110.6).   -
Tubulin and lamin A were used as controls for Cyt and NE fractions, respectively. One representative Western blot is shown (n = 2). Quan-
tifi cation of total cytosolic and nuclear O-GlcNAc modifi ed proteins was analyzed by Image J. All values are given as mean ± SEM (n = 4–5). 
* P < 0.05, ** P < 0.01, *** P < 0.001 compared with fasted within experimental group.  ## P < 0.01,  ### P < 0.001 compared with refed between 
indicated groups. ns, not signifi cant. 
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to be mediated by SREBP-1, because its expression is 
dependent on LXR ( 5, 47 ). Furthermore, we performed a 
liftover of rat ChREBP ChIP-Sequencing profi les to mouse 
DNA and designed ChIP primers corresponding to ChREBP 
binding peaks in rat  Fas ,  Scd1 , and  Acc promoters, but we 
were unable to detect ChREBP recruitment to the corre-
sponding genomic regions in mouse liver extracts from 
control or STZ-treated wild-type or LXR   /   mice (Mandrup 
et al., unpublished observations ). Future studies designed to 
delineate the relative role of LXR, SREBP-1c, and ChREBP 
in response to different diets and glucose levels will be im-
portant to further address their cooperative or indepen-
dent regulation of lipogenic genes. 
 In the present study, we show that  Chrebp  expression 
was blunted in STZ-treated LXR   /   mice, which is consis-
tent with  Chrebp  being an LXR target gene in liver ( 6, 13, 
27 ). However, ChREBP  mRNA and protein levels were 
minimally affected by LXR defi ciency in refed control 
mice, suggesting that ChREBP  expression becomes highly 
dependent on LXR in the absence of insulin. In line with 
these observations, we show that high glucose induced 
ChREBP  promoter activity through LXR in vitro, an ef-
fect that was inhibited by OGT depletion. Guinez et al. 
( 25 ), reported increased ChREBP protein expression , but 
 To discriminate between insulin and dietary activation 
of LXR in vivo, we subjected LXR +/+ and LXR   /   control 
and STZ-treated mice to a fasting-refeeding regime. The 
mice were fed a diet containing no cholesterol, omitting 
effects of dietary oxysterols on LXR activity. We show that 
LXRs regulate essential genes in the glycolytic and fatty 
acid synthesis pathway;  Gk ,  L-pk Srebp-1 ,  Chrebp  /  ,  Fas , 
 Acc  ,  Acc  ,  Scd1 , and  Gpat in response to feeding also in 
the absence of insulin. The refeeding-induction of these 
genes was blunted in LXR   /   control and hyperglycemic 
mice and correlated with lower protein levels of GK, L-PK, 
FAS, and SCD1 and serum TGs in LXR   /   mice, support-
ing the notion that LXRs are important glucose sensors of 
hepatic lipogenesis ( 13, 15 ), as glycolysis is dominant in 
the fed state when glucose is abundant ( 42 ). Recent ChIP-
Sequencing analyses of LXR and SREBP-1 binding profi les 
in mouse liver and ChREBP binding in human HepG2 
cells have revealed that their chromatin binding occurs 
at many genes involved in lipid metabolism ( 39, 41, 51 ). 
Moreover, mice defi cient in LXR ( 5, 52 ), ChREBP ( 53 ), or 
SREBP-1c ( 54 ) all exhibit reduced expression of lipogenic 
enzymes, indicating that they each have prominent roles 
in the lipogenic pathway. The expression levels of lipo-
genic genes observed in LXR   /   mice are not expected 
 Fig.  5. LXR regulates O-GlcNAcylation of ChREBP and binding of ChREBP  to the  L-PK promoter. A: Nuclear lysates were subjected to 
sWGA to precipitate GlcNAcylated proteins and immunoblotted with antibodies against O-GlcNAc (CTD 110.6), LXR, SREBP-1, and 
ChREBP (left panel). SREBP-1 was not recovered on sWGA beads (data not shown). Each lane represents independent mice from experi-
mental groups. One representative Western blot is shown (n = 2). Specifi city of the sWGA binding was confi rmed by GlcNAc (0.5 M) com-
petition (right, upper panel). sWGA from STZ-treated mice are shown in the lower panel. B: ChREBP binding to the ChORE containing 
region promoter of  L-PK was detected by ChIP using antibodies against ChREBP or IgG as a control. Values are shown as mean ± SEM 
(n = 4–5). * P < 0.05, ** P < 0.01 compared with fasted within experimental groups.  # P < 0.05 compared with refed within control or STZ 
treatment. 
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dependent on LXRs in both control and STZ-mice, which sug-
gests a role for LXRs in regulating ChREBP  DNA binding 
and/or its transactivating activity on the  ChREBP  promoter 
under both physiological and hyperglycemic conditions be-
cause ChREBP  has been shown to regulate the  ChREBP  
promoter in response to postprandial glucose levels ( 28 ). 
 ChREBP activity has been reported to be dependent on 
glucose metabolites downstream of GK ( 22 ). In our study, 
feeding induced ChREBP  activity (increased ChREBP  -
specifi c target gene expression of  Chrebp  and  L - pk and 
increased ChREBP promoter binding to the  L-Pk pro-
moter) in both control and STZ-treated mice, supporting 
increased GK-mediated G-6-P synthesis above fasting levels 
no increase in total  Chrebp mRNA expression in liver and 
primary hepatocytes isolated from mice with adenoviral 
overexpression of OGT, arguing against a role for LXR in 
mediating a transcriptional glucose-response via O-GlcNAc 
on ChREBP  . However, these experiments were performed 
in the presence of insulin, and relative expression of 
ChREBP  and ChREBP  isoforms were not investigated. 
 In agreement with earlier observations ( 28, 55 ), feeding 
in both mouse models strongly induced mRNA expression 
of  Chrebp  , which is believed to have higher activity than 
ChREBP  due to a lack of the N-terminal low glucose in-
hibitory domain and constitutive nuclear localization ( 28 ). 
Feeding-regulation of  Chrebp  mRNA expression was 
 Fig.  6. LXR and OGT colocalize and interact. A: Colocalization of overexpressed Cherry-OGT and GFP-LXR  or GFP-LXR  in Huh7 
cells under high glucose conditions (25 mM). Twenty-four hours after transfection, cells were treated for 2 h with DMSO or 1   M of 
GW3965. B: GST pulldown of bacterial lysates coexpressing His-OGT and GST, GST-LXR  or GST-LXR  . Precipitated proteins were 
subjected to SDS-PAGE and immunoblotted with antibodies against GST or OGT (AL28). C: Huh7 cells were cotransfected with HA-OGT 
and FLAG-LXR  or FLAG-LXR  plasmids and incubated for 24 h under high glucose conditions. Immunoprecipitations (IP) of OGT 
and FLAG-LXRs were blotted with anti-FLAG and anti-OGT antibodies. Mouse IgG IP was performed as control. Input lysates (Inp, 5%) and 
immunoprecipitated proteins were subjected to SDS-PAGE and blotted with anti-FLAG and anti-OGT antibodies. D: Liver lysates pooled 
from three fed wild-type (WT) and LXR   /   male mice were immunoprecipitated with anti-OGT or rabbit IgG antibody. Immunoprecipi-
tated proteins were subject to SDS-PAGE and blotted with anti-OGT and anti-LXR antibodies. 
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mice, cytosolic protein O-GlcNAc levels were not reduced, 
suggesting that the effect of LXR on nuclear O-GlcNAc 
levels is not due to decreased fl ux through the HBP. In-
stead, we believe this is due to LXR-dependent expression 
of a protein(s) modulating HBP fl ux or OGT activity and/
or that LXR may infl uence nuclear substrate specifi city of 
OGT, which has been suggested for other OGT-interacting 
proteins ( 57 ). In support of the latter hypothesis, we ob-
served that OGT and LXR interact and colocalize in the 
nucleus. Because OGT has been shown to be an important 
coactivator of nutrient-responsive gene transcription ( 59–
61 ), we hypothesize a role for LXR in regulating substrate 
specifi city of OGT on specifi c target gene promoters. OGT 
has previously been shown to target and activate ChREBP  , 
leading to increased ChREBP protein stabilization and 
binding to the  L-pk promoter concomitant with increased 
DNL gene expression ( 25 ). This model is in agreement 
with our results showing reduced nuclear O-GlcNAc modi-
fi ed ChREBP, L-PK expression, and binding of ChREBP to 
the  L-pk promoter in LXR   /   mice, suggesting that LXRs 
potentiate ChREBP activity via regulation of  Gk expression 
and nuclear O-GlcNAc signaling. 
 In summary, we have found that LXRs act as postpran-
dial nutrient and glucose metabolic sensors upstream of 
ChREBP in vivo based on the following observations:  1 ) 
LXRs do not require insulin for activation of  Gk and 
lipogenic gene expression in response to refeeding, spe-
cifically, both SREBP-1c and ChREBP  expression is 
completely dependent on LXRs under hyperglycemic in-
sulin-independent conditions.  2 ) LXRs interact with and 
modify the activity of nuclear OGT, a sensor of glucose 
metabolic fl ux via the HBP.  3 ) Transactivation of the  L-PK 
promoter by glucose sensing ChREBP  is dependent 
on LXR.  4 ) In the absence of insulin, feeding-induced 
ChREBP  expression is dependent on LXR (in vivo), in 
part via glucose-O-GlcNAc-dependent signaling (in vitro) 
under hyperglycemic and hypoinsulinemic conditions. 
Furthermore, feeding-induced ChREBP activity appeared 
to be dependent on LXRs, as refl ected by decreased 
mRNA expression of  L-pk and  Chrebp  and no induction of 
ChREBP  L-pk promoter binding in refed LXR   /   control 
mice despite high ChREBP  protein expression (low 
Chrebp  expression). These fi ndings are supported by re-
duced RNA polymerase II recruitment to  L-pk in LXR   /   
compared with LXR +/+ mice treated with pharmacological 
LXR agonists ( 41 ). In contrast to our results, one study re-
ported that LXR is dispensable for ChREBP-activated DNL 
gene expression in high carbohydrate refed mice ( 26 ). 
However, in that study, the transcriptional level of  Gk was 
unaffected by the loss of LXR, suggesting different re-
sponses due to different diets and/or LXR mouse models. 
We observed lower GK mRNA and protein levels in LXR   /   
mice. The role of LXR in regulating GK is supported by 
reduced GK expression in LXR   /   mice ( 27, 45 ), reduced 
glucose phosphorylation to G-6-P by GK in LXR    /   mice 
( 49 ), elevated GK transcription in mice treated with phar-
macological LXR agonists ( 56 ), and LXR binding to an 
LXRE in  Gk promoter in rat liver extracts ( 7 ). Moreover, we 
report induced binding of LXR to a mouse LXRE in the GK 
promoter upon refeeding, with a similar trend in STZ-
treated mice. Elevated  Gk transcription in STZ-treated mice 
may be mediated by SREBP-1c ( 43 ), and possibly other tran-
scription factors or coactivator complexes recruited to LXR 
at the  GK promoter. We have previously shown that binding 
of LXR to the LXRE in the  SREBP-1c promoter was unaf-
fected by LXR agonist treatment, whereas RNA polymerase 
II was recruited to the  Srebp-1c gene upon LXR activation, 
supporting that LXR activation of target genes may be me-
diated by coregulator recruitment to some genes ( 41 ). 
 Surprisingly, we observed a strong reduction in nuclear 
O-GlcNAc signaling in the liver of control and STZ-treated 
refed LXR   /   mice. Despite lower GK expression in LXR   /   
 Fig.  7. LXR regulates ChREBP  activity in response to feeding. LXR regulates the hepatic expression of 
lipogenic enzymes directly and through SREBP-1c expression and ChREBP  activity in response to elevated 
postprandial glucose and insulin levels (Control). LXR maintains its ability to induce the expression of lipo-
genic target genes under hyperglycemic and hypoinsulinemic conditions (STZ), by regulating the expres-
sion of SREBP-1c and expression and activity of ChREBP  . 
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in determining the potential cross-talk among OGT, LXR, 
and ChREBP  /  and their relative activity in response to 
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